Medtronic Agrees to Pay $268 Million Over Recalled Leads
Written By: Rheingold, Valet, Rheingold, Ruffo & Giuffra LLP
Medtronic, Inc. has recently agreed to pay $268 million to settle claims involving their recalled Sprint Fidelis leads used in internal cardiac defibrillators. The lead had a higher incidence of fracturing causing the device to go off, shocking victims numerous times unnecessarily.
Our firm currently represents hundred of patients that have or had the recalled leads and are pleased to make this announcement.